CARL CARLSMED INC

Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference

Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference

CARLSBAD, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed will be presenting at the J.P. Morgan 2026 Healthcare conference on Wednesday, January 14th at 4:30-5:10 pm PT in San Francisco, CA. During the conference, Carlsmed Management will be hosting 1x1 investor meetings.

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations

Caroline Corner, PhD

Media

LeAnn Burton

Senior Director Brand Marketing



EN
16/12/2025

Underlying

CARLCARLSMED INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CARLSMED INC

 PRESS RELEASE
Free
CARL CARLSMED INC

Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Confe...

Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference CARLSBAD, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed will be presenting at the J.P. Morgan 2026 Healthcare conference on Wednesday, January 14th at 4:30-5:10 pm PT in San Francisco, CA. During the conference, Carlsmed Management will be hosting 1x1 investor meetings. About Carlsmed, Inc. Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions w...

December 16, 2025 1 EN
 PRESS RELEASE
Free
CARL CARLSMED INC

Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for ...

Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting First 50+ cervical cases completed; observations on initial clinical experience to be presented by early adopters at the Carlsmed CSRS Lunch Workshop CARLSBAD, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the U.S. commercial launch of its aprevo® Technology Platform for cervical fusion surgeries. Surgeons involved in the clinical evaluation will also pres...

December 3, 2025 1 EN
 PRESS RELEASE
Free
CARL CARLSMED INC

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthc...

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference CARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting at the 37th Annual Piper Sandler Healthcare conference on Wednesday, December 3rd at 9:00-9:25 am ET in New York, NY. During the conference, Carlsmed Management will be hosting 1x1 investor meetings. A live webcast will be available to registered participants. Following the presentation, the webcast replay w...

November 19, 2025 1 EN
 PRESS RELEASE
Free
CARL CARLSMED INC

Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-...

Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance Third quarter revenue of $13.1 million, representing 98% growth YoY  Raising full year 2025 revenue guidance to $49 million - $50 million CARLSBAD, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the third quarter ended September 30, 2025.  "We delivered another strong quarter with 98% revenue growth year-over-year, expanded ...

November 6, 2025 1 EN
 PRESS RELEASE
Free
CARL CARLSMED INC

Carlsmed Inc. to Report Third Quarter 2025 Financial Results on Novemb...

Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its third quarter 2025 financial results after market close on Thursday, November 6, 2025. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the start of t...

October 23, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch